Haozhou Tan

1.3k total citations · 2 hit papers
27 papers, 700 citations indexed

About

Haozhou Tan is a scholar working on Infectious Diseases, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Haozhou Tan has authored 27 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 13 papers in Molecular Biology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Haozhou Tan's work include SARS-CoV-2 and COVID-19 Research (14 papers), Computational Drug Discovery Methods (8 papers) and Viral Infections and Immunology Research (8 papers). Haozhou Tan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), Computational Drug Discovery Methods (8 papers) and Viral Infections and Immunology Research (8 papers). Haozhou Tan collaborates with scholars based in United States, Greece and China. Haozhou Tan's co-authors include Jun Wang, Yanmei Hu, Bin Tan, Chunlong Ma, Prakash D. Jadhav, Yu Chen, Maura V. Gongora, Xufang Deng, John S. Choy and Eric M. Lewandowski and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Haozhou Tan

22 papers receiving 697 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir

2023 167 citations Yanmei Hu, Eric M. Lewandowski et al. ACS Central Science profile →
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

2024 43 citations Bin Tan, Prakash D. Jadhav et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Haozhou Tan United States	13	427	339	229	142	61	27	700
Kristina Lanko Netherlands	9	300 0.7×	233 0.7×	216 0.9×	133 0.9×	51 0.8×	14	589
Justin Shields Canada	9	353 0.8×	288 0.8×	252 1.1×	107 0.8×	93 1.5×	12	743
Sakshi Tomar United States	11	474 1.1×	303 0.9×	245 1.1×	110 0.8×	41 0.7×	22	781
Carly Huitema Canada	10	406 1.0×	298 0.9×	204 0.9×	120 0.8×	36 0.6×	12	766
G.J. Lockbaum United States	13	250 0.6×	167 0.5×	164 0.7×	86 0.6×	62 1.0×	21	448
Mikołaj Żmudziński Poland	8	394 0.9×	325 1.0×	282 1.2×	115 0.8×	26 0.4×	9	699
Sarah E. St. John United States	8	639 1.5×	352 1.0×	274 1.2×	88 0.6×	55 0.9×	11	933
Jesús Urquiza Spain	7	265 0.6×	160 0.5×	141 0.6×	76 0.5×	30 0.5×	8	552
Daniel Brian Nichols United States	12	339 0.8×	129 0.4×	214 0.9×	97 0.7×	130 2.1×	18	701
Robert N. Kirchdoerfer United States	7	679 1.6×	168 0.5×	258 1.1×	32 0.2×	106 1.7×	13	926

Countries citing papers authored by Haozhou Tan

Since Specialization

Citations

This map shows the geographic impact of Haozhou Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haozhou Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haozhou Tan more than expected).

Fields of papers citing papers by Haozhou Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haozhou Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haozhou Tan. The network helps show where Haozhou Tan may publish in the future.

Co-authorship network of co-authors of Haozhou Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Haozhou Tan. A scholar is included among the top collaborators of Haozhou Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haozhou Tan. Haozhou Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Klose, Thomas, et al.. (2026). Rational design and in vivo validation of capsid inhibitors for enterovirus D68. Nature Communications.

Jadhav, Prakash D., Bin Tan, Haozhou Tan, et al.. (2025). Design of quinoline SARS-CoV-2 papain-like protease inhibitors as oral antiviral drug candidates. Nature Communications. 16(1). 1604–1604. 8 indexed citations

Lewandowski, Eric M., Xiujun Zhang, Haozhou Tan, et al.. (2025). Distal protein-protein interactions contribute to nirmatrelvir resistance. Nature Communications. 16(1). 1266–1266. 3 indexed citations

Li, Kan, Prakash D. Jadhav, Yu Wen, Haozhou Tan, & Jun Wang. (2025). Development of a Fluorescence Polarization Assay for the SARS-CoV-2 Papain-like Protease. ACS Pharmacology & Translational Science. 8(3). 774–784.

Tan, Haozhou, Kan Li, & Jun Wang. (2025). Serial viral passage and reverse genetics protocol for identifying the antiviral drug targets of EV-D68 antivirals. STAR Protocols. 6(3). 104053–104053.

Li, Kan, Yanmei Hu, Haozhou Tan, et al.. (2025). A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis. Nature Communications. 16(1). 5987–5987.

Tan, Haozhou, Qianru Zhang, Kan Li, et al.. (2025). Identification of naturally occurring drug-resistant mutations of SARS-CoV-2 papain-like protease. Nature Communications. 16(1). 4548–4548. 2 indexed citations

Tan, Bin, Prakash D. Jadhav, Haozhou Tan, et al.. (2024). Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model. Science. 383(6690). 1434–1440. 43 indexed citations breakdown →

Tan, Haozhou, Brian Pollard, Kan Li, & Jun Wang. (2024). Discovery of A-967079 as an Enterovirus D68 Antiviral by Targeting the Viral 2C Protein. ACS Infectious Diseases. 10(12). 4327–4336. 2 indexed citations

10.

Li, Ying, An Li, Yue Wang, et al.. (2024). CypA/TAF15/STAT5A/miR-514a-3p feedback loop drives ovarian cancer metastasis. Oncogene. 43(49). 3570–3585. 3 indexed citations

11.

McKay, Matthew J., et al.. (2024). Structure and dynamics of the proton-selective histidine and the gating tryptophan in an inward rectifying hybrid influenza B and A virus M2 proton channel. Physical Chemistry Chemical Physics. 26(30). 20629–20644.

12.

Wang, Jun, et al.. (2023). An Overview of Antivirals against Monkeypox Virus and Other Orthopoxviruses. Journal of Medicinal Chemistry. 66(7). 4468–4490. 34 indexed citations

13.

Hu, Yanmei, Eric M. Lewandowski, Haozhou Tan, et al.. (2023). Naturally Occurring Mutations of SARS-CoV-2 Main Protease Confer Drug Resistance to Nirmatrelvir. ACS Central Science. 9(8). 1658–1669. 167 indexed citations breakdown →

14.

Tan, Bin, M. Sacco, Haozhou Tan, et al.. (2023). Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors. European Journal of Medicinal Chemistry. 259. 115667–115667. 18 indexed citations

15.

Tan, Haozhou, Yanmei Hu, & Jun Wang. (2023). FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 Mpro and PLpro. STAR Protocols. 4(2). 102323–102323. 6 indexed citations

16.

Jadhav, Prakash D., Bo Huang, J. Osipiuk, et al.. (2023). Structure-based design of SARS-CoV-2 papain-like protease inhibitors. European Journal of Medicinal Chemistry. 264. 116011–116011. 12 indexed citations

17.

Tan, Haozhou, Chunlong Ma, & Jun Wang. (2022). Invalidation of dieckol and 1,2,3,4,6-pentagalloylglucose (PGG) as SARS-CoV-2 main protease inhibitors and the discovery of PGG as a papain-like protease inhibitor. Medicinal Chemistry Research. 31(7). 1147–1153. 16 indexed citations

18.

Cui, Meng, Haozhou Tan, Keman Xu, et al.. (2021). A benzopyran with antiarrhythmic activity is an inhibitor of Kir3.1-containing potassium channels. Journal of Biological Chemistry. 296. 100535–100535. 7 indexed citations

19.

Ma, Chunlong, Zilei Xia, M. Sacco, et al.. (2021). Discovery of Di- and Trihaloacetamides as Covalent SARS-CoV-2 Main Protease Inhibitors with High Target Specificity. Journal of the American Chemical Society. 143(49). 20697–20709. 106 indexed citations

20.

Ma, Chunlong, et al.. (2021). Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays. Acta Pharmaceutica Sinica B. 12(4). 1636–1651. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact